Laurence Van Brée, PhDClinical Disclosure Office at NovartisSpeaker
Profile
Laurence Van Bree is an expert in clinical transparency and disclosure with over 25 years of experience in clinical research. At Novartis, she led the implementation of EU-CTR/CTIS transparency and disclosure related processes, the rollout of plain language trial summaries, and the company-wide review and oversight of Protocol Lay Synopses. She also served as co-lead of the DIA EU-CTR Working Group (2022-23), represented Novartis as Sponsor at external meetings, including DIA.
Agenda Sessions
Ensuring Timely Production of Lay Summaries—Strategies, Approaches, and Real-World Implementation
, 11:45View Session